Search - tctmd.com

Displaying 121 - 140 of 239

Sort: Relevancy | Date

News Daily News

Next-Day Discharge Safe Following Minimalist TAVR, Study Shows

Michael O'Riordan

January 16, 2018

News Daily News

Sex Differences Diminish With Third-Generation TAVR Device

L.A. McKeown

January 05, 2018

News Daily News

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

Shelley Wood

December 19, 2017

News Conference News TCT 2017

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

Ashley Lyles

November 08, 2017

News Conference News TCT 2017

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Michael O'Riordan

October 31, 2017

News Daily News

Long-term Evidence Supports Better Survival for Women Than Men After TAVR

L.A. McKeown

October 23, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

News Conference News PCR London Valves 2017

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Shelley Wood

September 27, 2017

News Daily News

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Ashley Lyles

August 08, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Conference News TVT 2017

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Michael O'Riordan

June 20, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

Presentation TVT 2017

Incidence, Predictors, and Consequences of Permanent Pacemakers after TAVR

Presenter: Tamim Nazif

June 15, 2017

News Daily News

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Michael O'Riordan

June 06, 2017

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

News Daily News

Balloon Predilation Not Mandatory Before TAVR, Meta-analysis Suggests

Caitlin E. Cox

April 21, 2017

News Daily News

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

L.A. McKeown

April 12, 2017

Presentation

A Highly Predictive Risk Model for New Permanent Pacemaker Implantation After Sapien 3 TAVR

April 12, 2017

News Conference News ACC 2017

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Todd Neale

March 17, 2017

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

Advertisement

Next-Day Discharge Safe Following Minimalist TAVR, Study Shows

Sex Differences Diminish With Third-Generation TAVR Device

Novel Repositionable TAVR Device Sees Low Pacemaker Rates and Few Leaks

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Long-term Evidence Supports Better Survival for Women Than Men After TAVR

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Incidence, Predictors, and Consequences of Permanent Pacemakers after TAVR

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Balloon Predilation Not Mandatory Before TAVR, Meta-analysis Suggests

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

A Highly Predictive Risk Model for New Permanent Pacemaker Implantation After Sapien 3 TAVR

SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content